Trent grants 11.13 lakh stock options under ESOP 2026
Trent Limited's NRC approved granting 11,13,500 stock options at ₹2,652 per share under ESOP 2026. The options vest subject to performance conditions and are exercisable within one year of vesting.

*this image is generated using AI for illustrative purposes only.
Trent Limited has approved the grant of 11,13,500 stock options to eligible employees under its Employee Stock Option Plan 2026. The decision was taken by the company's Nomination and Remuneration Committee during a meeting held on June 19, 2026. This move follows shareholder approval obtained via a postal ballot on May 27, 2026.
The granted options are exercisable into an equivalent number of fully paid-up equity shares, each with a face value of ₹1. The exercise price for these options has been fixed at ₹2,652 per share. The scheme is compliant with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
Key Details of the Grant
The options will vest based on the fulfilment of performance conditions prescribed by the Nomination and Remuneration Committee. Once vested, the options can be exercised within a maximum period of one year from the date of vesting. As of the current date, no options have vested, exercised, or lapsed.
| Particulars | Description |
|---|---|
| Options Granted | 11,13,500 |
| Exercise Price | ₹2,652 per share |
| Face Value | ₹1 per share |
| Vesting Period | At discretion of Committee, subject to performance conditions |
| Exercise Period | Within 1 year from vesting date |
| Options Vested | Nil |
| Options Exercised | Nil |
The committee's meeting commenced at 11 a.m. and concluded at 2:30 p.m. on June 19, 2026. The disclosure was submitted to the stock exchanges in compliance with Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
Historical Stock Returns for Trent
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.82% | +18.26% | +19.25% | +19.32% | -16.15% | +466.26% |
What specific performance conditions has the Nomination and Remuneration Committee set for the vesting of these options?
How will the issuance of these 11.13 lakh new shares impact Trent's existing earnings per share (EPS) upon exercise?
Does this grant indicate a shift in Trent's retention strategy, and are further ESOP grants expected in the near future?
































